1.
Validation of LC-MS/MS Method for Monitoring of Upadacitinib in Rat Plasma Samples. Journal of Pharmaceutical Negative Results. 2022;13(2):102-107. Accessed June 24, 2026. https://www.pnrjournal.com/index.php/home/article/view/196